View full database Titration protocol to 12 mg (retatrutide (triple GLP-1 / GIP / glucagon agonist)) Starting dose (Phase 3 TRIUMPH) First increase Second increase Maximum studied dose Injection once weekly (per study protocol), subcutaneous (abdomen, thigh or upper arm)
The FDA advises patients to inform their healthcare providers of palpitations or feelings of a racing heartbeat while at rest. Those who experience sustained increases in resting heart rate should discontinue the medication
It has been available on the market since 2017, and people were initially using Semaglutide as a medication for type 2 diabetes under the brand name Ozempic
He wrote that he struggled with his weight for most of his life, and being scrutinized by the media and public eye only added to his problems
Many patients were not informed by Novo Nordisk or their doctors that blindness caused by NAION was a potential complication
This cost is one of the most common complaints, especially when compared to the more affordable generic alternatives
.webp)
